U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...

Other countries

Results: 1 to 6 of 6

Tests names and labsConditionsGenes, analytes, and microbesMethods

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics
United States
345159
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cerebral Cavernous Malformations Panel

PreventionGenetics
United States
33
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene, Exon 10

PreventionGenetics
United States
11
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Cerebral cavernous familial: KRIT1 gene mutation analysis (c.1363C>T, dG699, Q698X)

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • T Targeted variant analysis

Results: 1 to 6 of 6

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.